Status:
NOT_YET_RECRUITING
The PreEclampsia Postpartum Prevention Trial
Lead Sponsor:
Karolinska Institutet
Conditions:
Preeclampsia
Postpartum Period
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if a postpartum bundle intervention can improve cardiometabolic health and lifestyle-related factors in women who have had preeclampsia during their first p...
Detailed Description
PURPOSE AND AIMS: The overall aim of this 9-month multicentre, two-arm, single-blind, parallel-group RCT across several regions in Sweden is to improve cardiometabolic health in women after a first p...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- First-time mothers postpartum
- Preeclampsia during first pregnancy
- Age ≥ 18 years
- Singleton live birth (infant still alive)
- Ability to understand and speak Swedish, English, Arabic, Somali, Dari, Persian, or Spanish
- Having a smartphone (Android or iOS)
- Ability to provide informed consent
- Exclusion Criteria:
- Pre-pregnancy hypertension
- Diabetes mellitus type I or II
- Cardiovascular disease
- Kidney disease
- Systemic lupus erythematosus
- Antiphospholipid syndrome
- Previous or current eating disorders
- Ongoing new pregnancy
Exclusion
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2029
Estimated Enrollment :
760 Patients enrolled
Trial Details
Trial ID
NCT07199283
Start Date
November 1 2025
End Date
May 1 2029
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institutet
Stockholm, Stockholm County, Sweden, 17177